Table 1.
Follow-up, by Type of Symptoms at Diagnosis | ||||||||||
Baseline (N = 504) | Follow-up (N = 504) | Hyperglycemia (n = 163) | Unrelated (n = 96) | None (n = 207) | ||||||
Parameter | No.* | Baseline | No.† | Change | No.† | Change | No.† | Change | No.† | Change |
Weight, lb | 452 | 207.7 | 442 | −6.6‡ | 133 | −6.7‡ | 85 | −63.8‡ | 184 | −6.5‡ |
HbA1c, % | 452 | 8.8 | 452 | −1.7‡ | 102 | −2.8‡ | 62 | −1.1‡ | 138 | −1.2‡ |
SBP, mm Hg | 471 | 137.5 | 439 | −4.3‡ | 132 | −3.5§ | 87 | −2.5 | 181 | −6.2‡ |
DBP, mm Hg | 471 | 80.7 | 438 | −3.4‡ | 132 | −3.9‡ | 86 | −3.0 | 181 | −3.9‡ |
Aspirin use, % | 504 | 15.3 | 504 | +10.8‡ | 163 | +6.8§ | 96 | +17.7§ | 207 | +11.6§ |
LDL-cholesterol, mg/dL | 200 | 133.4 | 136 | −4.8§ | 41 | −5.6 | 26 | −2.7 | 55 | −6.2 |
HbA1c = hemoglobin A1c; SBP = systolic blood pressure; DBP = diastolic blood pressure; LDL = low-density lipoprotein.
* Number of patients with baseline value for the designated measure.
† Number of patients with both baseline and follow-up values for the designated measure.
‡ P <.01.
§ P <.5.